Quality Specialist
Purpose
The purpose of this memorandum is to justify the addition of dedicated Quality Assurance In-Process (QAIP) personnel to support the upcoming 503B operations at the Tamarac manufacturing site. The expansion of sterile manufacturing activities into 503B operations will significantly increase the level of Quality oversight required to ensure compliance with current Good Manufacturing Practice (cGMP) regulations, maintain product quality, and support uninterrupted manufacturing operations.
Current State
The Quality Operations department currently staffs one QA In-Process (QAIP) Specialist per manufacturing shift (two working shifts). While this staffing model has been adequate to support existing operations, each QAIP is responsible for numerous critical quality oversight activities throughout the facility, including but not limited to:
Room release prior to manufacturing operations
In-process inspections during manufacturing
Review of manufacturing area and equipment logbooks
Verification of entries within executed in-process batch records
Routine Quality walkthrough inspections of manufacturing areas
Collection of retention samples
Oversight of line clearance activities
Verification of cGMP compliance during manufacturing operations
Support of deviation identification and immediate quality assessments
General Quality presence on the manufacturing floor
These activities require continuous interaction with Manufacturing personnel and must be performed in real time to ensure compliance with internal procedures and regulatory expectations.
Impact of 503B Operations
The implementation of 503B operations will substantially increase the demand for Quality oversight within the manufacturing environment. Unlike current operations, 503B production will require increased QA presence throughout the manufacturing process due to the nature of compounded sterile drug production and the heightened regulatory expectations associated with aseptic processing.
Additional QA oversight will be necessary to support:
Continuous monitoring of critical manufacturing activities
Increased verification of aseptic practices and operator compliance
Enhanced oversight of environmental controls and cleanroom practices
Timely review and documentation of in-process activities
Immediate assessment and escalation of quality events
Increased coordination with Manufacturing during production campaigns
Verification of process compliance throughout the manufacturing operation
These responsibilities cannot reasonably be absorbed by the current QAIP staffing model without negatively affecting routine Quality oversight across the remainder of the facility.
Additional activities
The role of the Quality and Compliance department has been expanded to include production supply supplier qualification.
In addition to these activities, Quality needs to begin establishing the Annual Product Quality Review system and implementing a continuous monitoring program.
Operational Risks
Maintaining only one QAIP per shift while introducing 503B manufacturing presents several operational and compliance risks, including:
Reduced Quality presence on the manufacturing floor
Delays in completion of required Quality inspections and verifications
Increased potential for missed or delayed identification of quality events
Reduced responsiveness to Manufacturing support requests
Increased workload leading to personnel fatigue and higher potential for human error
Limited flexibility to support concurrent manufacturing operations
Insufficient coverage during employee absences, meetings, investigations, or training activities
Additionally, the Tamarac site continues to execute multiple operational projects and process-improvement initiatives, further increasing the daily workload of QAIP personnel. As manufacturing operations continue to expand, existing resources are approaching maximum capacity.
Education
B.A. /B.S. degree and a minimum of one to three years of related experience. Must be familiar with overall pharmaceutical manufacturing and quality systems/process.
Knowledge, Skills and Abilities
Strong knowledge of cGMP regulations and pharmaceutical quality systems.
Experience in manufacturing processes, aseptic processing, and documentation.
Attention to detail with a commitment to accuracy and data integrity.
Ability to manage multiple assignments in a dynamic, fast-paced environment.
Proficiency in Microsoft Office applications, including Word, Excel, PowerPoint, and Outlook.
Strong interpersonal and collaboration skills, with the ability to work effectively across departments.
Ability to interpret and follow written procedures and regulatory requirements.